It is a pharma private limited company based in Gujarat, Gujarat, India, established in 1996.
1996 | Gujarat, Gujarat, India | ActiveSwana Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 1996 in Gujarat, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231GJ1996PTC030921. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr.
It upholds a compliant status. Its leadership includes Sushilaben Shatishkumar Patel (Director), Pravinkumar Manilal Patel (Director). Past directors included Satishkumar Manilal Patel, Sanatbhai Ambalal Patel, Mamtaben Sandeepbhai Shah. It holds no open charges and ₹7.12 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 20 Shroff Society Viroldarwaja Mahmedabad, Gujarat, Gujarat, 387130.
U24231GJ1996PTC030921
030921
15 October 1996
₹1.25 Cr
₹1.25 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Swana Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushilaben Shatishkumar Patel | Director | 06 May 2019 | Current |
| Pravinkumar Manilal Patel | Director | 06 Jul 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jul 2020 | Past |
| Pramod Abcsdd | Director | 11 Jul 2014 | Past |
| Pramod Abcsdd | Director | 07 May 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Swana Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.58% increase. The company also saw a substantial improvement in profitability, with a 155.8% increase in profit. The company's net worth Soared by an impressive increase of 16.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Swana Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹7,120,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2001 | Indian Overseas Bank | ₹0.80 M | Satisfied |
| 06 Sep 2001 | Indian Overseas Bank | ₹6.32 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Swana Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Swana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swana Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Swana Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Swana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Pravinkumar Manilal Patel was appointed as a Director was appointed as a Director on 06 Jul 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on Sushilaben Shatishkumar Patel was appointed as a Director was appointed as a Director on 06 May 2019 & has been associated with this company since 6 years 7 months . was documented.
The activity A charge registered on 21 Sep 2001 via Charge ID 90102124 with Indian Overseas Bank was fully satisfied on 28 Mar 2017. was completed.
Progress on A charge registered on 06 Sep 2001 via Charge ID 90102121 with Indian Overseas Bank was fully satisfied on 28 Mar 2017. was documented.
The CIN of Swana Pharmaceuticals Private Limited is U24231GJ1996PTC030921.
Swana Pharmaceuticals Private Limited is headquartered at 20 Shroff Society Viroldarwaja Mahmedabad, Gujarat, Gujarat, 387130.
Swana Pharmaceuticals Private Limited was incorporated on 15 October 1996.
The current directors of Swana Pharmaceuticals Private Limited are
The primary industry of Swana Pharmaceuticals Private Limited is Manufacturing.
Swana Pharmaceuticals Private Limited is unlisted.
The authorized capital of Swana Pharmaceuticals Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.25 Cr.
The compliance status of Swana Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX